Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by love_minus_zeroon Aug 23, 2007 3:58pm

154 Views

Post# 13292137

RE: bmo buying

For those that dont have level two the broker to broker trades indicate a buy if the next ask is higher. And vice versa, if the broker to broker is a sell the resulting next price will be lower. These were buys as it pushed it up 25 cents. I love those BMO boys and girls. lmz nows the time folks, BMO has wrung the everythings ok alarm.

Bullboard Posts

Level up your trading with BMO InvestorLine’s enhanced features